tadalafil + alpha1 blocker

**tadalafil + alpha1 blocker** is a pharmacological combination used for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), especially in men with concurrent erectile dysfunction (ED). This regimen combines **tadalafil**, a phosphodiesterase type 5 (PDE5) inhibitor, with an **alpha1 blocker** (such as alfuzosin or tamsulosin). Tadalafil acts by inhibiting PDE5, resulting in smooth muscle relaxation in the prostate, bladder, and penile tissues, improving urinary and erectile function. Alpha1 blockers antagonize adrenergic alpha1 receptors on smooth muscle in the lower urinary tract, leading to decreased sympathetic tone and improved urine flow. The combination demonstrates additive effects in relaxing detrusor and prostatic smooth muscle, improving symptoms of LUTS and ED. Clinical studies show this combination is generally well tolerated with a low risk of hypotensive adverse events when used appropriately[1][2][3][4].

Brand names

Dufatad

Other names

Tamsulosin Hydrochloride / Tadalafil CombinationTamsulosin and Tadalafil Fixed-Dose Combination